基于医药经济运行数据的新医改纵深发展视角下我国医药产业发展现状及趋势分析  

Current situation and trend analysis of China′ s pharmaceutical industry from the perspective of new medical reform deep development based on the data of pharmaceutical economic operation

作　　者：肖晗[1] 朱民田[1] 张思文[1] XIAO Han;ZHU Mintian;ZHANG Siwen(School of Economics and Management,Liaoning University of Traditional Chinese Medicine,Liaoning Province,Shenyang 110032,China)

机构地区：[1]辽宁中医药大学经济管理学院,辽宁沈阳110032

出　　处：《中国医药导报》2018年第36期156-161,173,共7页China Medical Herald

基　　金：辽宁省社会科学规划基金项目(L17BJY008);辽宁省教育厅人文社会科学研究项目(L201617)

摘　　要：新医改已进行了近10年的时间。我国医药卫生事业进行了一系列改革,某些领域取得了突破性进展,但某些深层次的问题仍未得到根本性解决。本文采用2005～2017年中国医药经济运行数据,从政治、经济、社会和技术几方面入手,对我国医药产业发展现状及趋势进行了分析,发现我国政策环境变化巨大,自主创新能力有所增强但仍落后,产业集中度有所提升,公立基层医疗终端市场份额将稳步提高。这为我国医药产业合理布局与发展提供了借鉴。The new medical reform has been carried out for nearly 10 years. China′s medical and health undertakings have undergone a series of reforms and made great breakthroughs in some fields, but some deep-seated problems have not yet been fundamentally solved. Based on the data from 2005 to 2017 on the economic operation of Chinese medicine, the current situation and trend of the development of Chinese medicine industry were analyzed from the political, economic, social and technological aspects in this article. It was found that the policy environment of our country has changed greatly, the ability of independent innovation has been enhanced but still lagged behind, the concentration of industry has been improved, and the market share of public primary medical terminals will be steadily increased. This provides a reference for the rational distribution and development of China′s pharmaceutical industry.

关 键 词：医药产业 新医改 政策 创新 趋势 

分 类 号：F426.72[经济管理—产业经济]